Evidence map›Paper›PMID 35109800›Full record

ArticleBMC pediatrics2022

Novel heterozygous compound TRMT5 mutations associated with combined oxidative phosphorylation deficiency 26 in a Chinese family: a case report.

Shuiyan Wu, Weixi Li, Zhenjiang Bai, Saihu Huang, Daoping Yang, Hongmei Chen, Ying Li, Ying Liu, Haitao Lv

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shuiyan Wu *Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China.
Weixi Li *Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China.
Zhenjiang Bai *Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China.
Saihu HuangPediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China.
Daoping YangDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China.
Hongmei ChenPediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China.
Ying LiPediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China.
Ying LiuInstitute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China. d201077400@alumni.hust.edu.cn.
Haitao LvDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, Jiangsu Province, 215025, P.R. China. haitaolvsoochow1@163.com.
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCombined oxidative phosphorylation deficiency 26 (COXPD26) is an autosomal recessive disorder characterized by early onset, developmental delay, gastrointestinal dysfunction, shortness of breath, exercise intolerance, hypotonia and muscle weakness, neuropathy, and spastic diplegia. This disease is considered to be caused by compound heterozygous mutations in the TRMT5 gene. CASE PRESENTATION: In this study, we report a female child with COXPD26 manifesting as shortness of breath, gastrointestinal dysmotility, severe developmental delay, muscle hypotonia and weakness, exercise intolerance, renal and hepatic defects, and recurrent seizures with spastic diplegia. Interestingly, the hepatic feature was first observed in a COXPD26 patient. Medical exome sequencing with high coverage depth was employed to identify potential genetic variants in the patient. Novel compound heterozygous mutations of the TRMT5 gene were detected, which were c.881A>C (p.E294A) from her mother and c.1218G>C (p.Q406H) and c.1481C>T (p.T494M) from her father.

conclusionThe newly emerged clinical features and mutations of this patient provide useful information for further exploration of genotype-phenotype correlations in COXPD26.

Indexed as

Cerebral PalsyMitochondrial DiseasesChinaDyspneaFemaleHumansMuscle HypotoniaMutationPedigreetRNA MethyltransferasesTRMT5 protein, humantRNA MethyltransferasesCase reportCOXPD26Medical exome sequencingMutationTRMT5

Identifiers

PMID35109800
PMCPMC8808961
OpenAlexW4210714791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.